KloosRT, EngC, EvansDB, FrancisGL, GagelRF, GharibH, MoleyJF, PaciniF, RingelMD, SchlumbergerM, WellsSAJr. 2009. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid, 19:565–612.
2.
GimmO, MarshDJ, AndrewSD, FrillingA, DahiaPL, MulliganLM, ZajacJD, RobinsonBG, EngC. 1997. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab, 82:3902–3904.
3.
JasimS, YingAK, WaguespackSG, RichTA, GrubbsEG, JimenezC, HuMI, CoteG, HabraMA. 2011. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid, 21:189–192.
4.
SmithDP, HoughtonC, PonderBA. 1997. Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene, 15:1213–1217.
